Suppr超能文献

综合分析显示,PIAS 家族基因的表达与预后、免疫调节和化疗相关。

Integrative analysis revealed a correlation of PIAS family genes expression with prognosis, immunomodulation and chemotherapy.

机构信息

The Research Center for Preclinical Medicine, Southwest Medical University, Luzhou, 646000, Sichuan, China.

Pharmaceutical Institute, Henan University, Kaifeng, 475004, China.

出版信息

Eur J Med Res. 2024 Mar 25;29(1):195. doi: 10.1186/s40001-024-01795-7.

Abstract

BACKGROUND

Protein inhibitor of activated STATs (PIAS) has pleiotropic biological effects, such as protein post-translational modification, transcriptional coregulation and gene editing. It is reported that PIAS family genes are also correlated with immune cells infiltration in cancers that highlights their unnoticed biological role in tumor progression. However, the relationship of their expression with prognosis, immune cell infiltration, tumor microenvironment, and immunotherapy in pan-cancer has been rarely reported.

METHODS

The multi-omics data were used to investigate the expression level of PIAS family members in pan-cancer, and the prognostic value of their expression in different tumors was analyzed by univariate Cox regression and Kaplan-Meier. Correlation analysis was used to investigate the relationship of PIAS gene expression with tumor microenvironment, immune infiltrating subtypes, stemness score and drug sensitivity. In addition, we also used wound healing and transwell assays to verify the biological effects of PIAS family gene expression on invasion and metastasis of HCC cells.

RESULTS

We found that PIAS family genes expression is significantly heterogeneous in tumors by multi-genomic analysis, and associated with poor prognosis in patients with multiple types of cancer. Furthermore, we also found that genetic alterations of PIAS family genes were not only common in different types of human tumors, but were also significantly associated with disease-free survival (DFS) across pan-cancer. Single-cell analysis revealed that PIAS family genes were mainly distributed in monocytes/macrophages. Additionally, we also found that their expression was associated with tumor microenvironment (including stromal cells and immune cells) and stemness score (DNAss and RNAss). Drug sensitivity analysis showed that PIAS family genes were able to predict the response to chemotherapy and immunotherapy. PIAS family genes expression is closely related to tumor metastasis, especially PIAS3. High PIAS3 expression significantly promotes the migration and invasion of liver cancer cell lines (HCC-LM3 and MHCC97-H).

CONCLUSIONS

Taking together, these findings contribute to determine whether the PIAS family genes are a potential oncogenic target gene, which have important contribution for the development of cancer immunotherapy.

摘要

背景

蛋白抑制剂激活 STAT(PIAS)具有多种生物学效应,如蛋白质翻译后修饰、转录共调节和基因编辑。据报道,PIAS 家族基因也与癌症中的免疫细胞浸润相关,这凸显了它们在肿瘤进展中未被注意到的生物学作用。然而,它们的表达与预后、免疫细胞浸润、肿瘤微环境和免疫治疗在泛癌中的关系很少有报道。

方法

使用多组学数据研究 PIAS 家族成员在泛癌中的表达水平,并通过单因素 Cox 回归和 Kaplan-Meier 分析不同肿瘤中它们表达的预后价值。相关性分析用于研究 PIAS 基因表达与肿瘤微环境、免疫浸润亚型、干性评分和药物敏感性的关系。此外,我们还使用划痕愈合和 Transwell 测定来验证 PIAS 家族基因表达对 HCC 细胞侵袭和转移的生物学影响。

结果

通过多基因组分析,我们发现 PIAS 家族基因的表达在肿瘤中存在显著的异质性,并与多种类型癌症患者的预后不良相关。此外,我们还发现 PIAS 家族基因的遗传改变不仅在不同类型的人类肿瘤中很常见,而且与泛癌的无病生存(DFS)显著相关。单细胞分析表明,PIAS 家族基因主要分布在单核细胞/巨噬细胞中。此外,我们还发现它们的表达与肿瘤微环境(包括基质细胞和免疫细胞)和干性评分(DNAss 和 RNAss)相关。药物敏感性分析表明,PIAS 家族基因能够预测化疗和免疫治疗的反应。PIAS 家族基因的表达与肿瘤转移密切相关,尤其是 PIAS3。高 PIAS3 表达显著促进肝癌细胞系(HCC-LM3 和 MHCC97-H)的迁移和侵袭。

结论

综上所述,这些发现有助于确定 PIAS 家族基因是否是一种潜在的致癌靶基因,这对癌症免疫治疗的发展有重要贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69c5/10962104/280e64bffda8/40001_2024_1795_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验